Methotrexate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Methotrexate Injection (injection) from Assertio Specialty Pharmaceuticals, LLC with status To Be Discontinued. The shortage was first posted on 08/29/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Assertio Specialty Pharmaceuticals, LLC
- Package NDC
- 82497-020-04
- Dosage Form
- Injection
- Presentation
- Otrexup, Injection, 20 mg/.4 mL (NDC 82497-020-04)
- Initial Posting
- 08/29/2025
- Revised Date